Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kinnunen, A.
Right arrow Articles by Surcel, H.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinnunen, A.
Right arrow Articles by Surcel, H.-M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 7, 1484-1489, July 2000
© 2000 European Society of Human Reproduction and Embryology

Chlamydia trachomatis reactive T lymphocytes from upper genital tract tissue specimens

A. Kinnunen1, P. Molander3, A. Laurila1, I. Rantala4, R. Morrison5, M. Lehtinen2, R. Karttunen6, A. Tiitinen3, J. Paavonen3 and H.-M. Surcel1,7

1 National Public Health Institute, Aapistie 1, Box 310, 90101 Oulu, Finland and 2 Helsinki, 3 Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, 4 Pathology Unit, Tampere University Hospital, Tampere, 5 Department of Medical Microbiology, University of Oulu, Finland and 6 Department of Microbiology, Montana State University, Bozeman, MT, USA

Chlamydia trachomatis infection is associated with pelvic inflammatory disease (PID) and tubal factor infertility (TFI). We investigated the role of C. trachomatis as a target antigen of endometrial and salpingeal tissue lymphocytes derived from PID and TFI patients. Antigen specificity of the tissue originated T lymphocyte lines (TLL) was tested against C. trachomatis elementary bodies and chlamydial heat shock protein 60 (CHSP60). C. trachomatis antigen stimulated proliferation in two out of eight endometrial TLL derived from PID patients and three out of four TLL derived from TFI patients. All (n = 4) TLL derived from the salpingeal specimens responded to CHSP60 compared with only one out of 12 TLL derived from the endometrial specimens. In-vivo expression of interferon-gamma (IFN-{gamma}) mRNA revealed that it was present in nine of 13 specimens obtained from PID patients. The dominant activity of type-1 T lymphocytes was confirmed by the in-vitro production of IFN-{gamma} (median 1007 pg/ml) from all (n = 5) C. trachomatis specific TLL while IL-5 secretion was lower (median 779 pg/ml). In conclusion, C. trachomatis reactive TLL were established from in-vivo activated lymphocytes from the upper genital tract tissue of PID and TFI patients. The reactivity of the salpingeal TLL to CHSP60 provided further evidence that immunoreactivity to CHSP60 is a predominant response in patients with tubal damage.

Key words: cell-mediated immunity/heat shock protein 60/IFN-{gamma}/pelvic inflammatory disease/tubal factor infertility

7 To whom correspondence should be addressed at: National Public Health Institute, Aapistie 1, Box 310, 90101 Oulu, Finland. E-mail: helja_marja.surcel{at}ktl.fi


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
A.H. Kinnunen, H-M. Surcel, M. Lehtinen, J. Karhukorpi, A. Tiitinen, M. Halttunen, A. Bloigu, R.P. Morrison, R. Karttunen, and J. Paavonen
HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study
Hum. Reprod., August 1, 2002; 17(8): 2073 - 2078.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.